Miraculins

Developing and Commercializing Diagnostic Tests for Unmet Clinical Needs

  • Skip Navigation
  • About Us
    • Corporate Profile
    • Our Process
      • Clear Strategies for Growth
      • Exceptional Product
      • Business Model
      • Strong Market
    • Executive Management
    • Scientific Team
    • Board of Directors
    • Message From the President & CEO
    • Corporate Fact Sheet
  • Research & Technology
    • The Miraculins Advantage
    • Publications
  • Products & Programs
    • Product Pipeline
    • Prostate Cancer Program
    • Preeclampsia Program
    • Colorectal Cancer Program
    • Pancreatic Cancer Program
    • Gastric Cancer Program
    • Breast Cancer Program
    • Resources
  • News
    • Press Releases
    • In the News
  • Investor Relations
    • Stock Information
      • Stock Quote & Chart
      • Transfer Agent
      • Analyst Coverage
    • Financial Filings
      • Financial Statements
      • Annual Reports
    • Investor FAQ
    • Corporate Governance
      • Corporate Governance Policy
      • Audit Committee Charter
      • Insider Trading Policy
      • Whistle Blower Policy
    • Events & Presentations
  • Careers
    • Job Postings
  • Home
  • Contact
  • Sitemap

Research & Technology

  • Print

Publications

Cancer Proteomics World Congress/Molecular Diagnostics World Congress, April 2007
43 kB PDF

American College of Gastroenterology Annual Scientific Meeting, October 2006
183 kB PDF

American Association for Cancer Research Molecular Targets & Therapeutics Conference, November 2005
207 kB PDF


  • The Miraculins Advantage
  • Publications

Sign Up for E-Mail Updates From Miraculins



Sign Up Now Privacy Policy

© 2007 Miraculins Inc. | Legal Information | Privacy Policy